Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma
Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma
JASINT 2
Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma
Therapeutic area :
Oncology
Disease :
Carcinoma of the urothelium
Study medication :
Vinflunine (Javlor®)
Phase :
Phase III
Start Date :
22 February 2016
End date :
08 January 2017
Study ID :
L00070 IN 312 P1
EudraCT/CTIS number :
2014-005396-82
Send by email